Annual Working Capital
-$1.09 M
-$305.90 K-38.90%
September 30, 2024
Summary
- As of February 12, 2025, SONN annual working capital is -$1.09 million, with the most recent change of -$305.90 thousand (-38.90%) on September 30, 2024.
- During the last 3 years, SONN annual working capital has fallen by -$23.20 million (-104.94%).
- SONN annual working capital is now -104.94% below its all-time high of $22.11 million, reached on September 30, 2021.
Performance
SONN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$1.09 M
-$3.11 M-154.13%
September 30, 2024
Summary
- As of February 12, 2025, SONN quarterly working capital is -$1.09 million, with the most recent change of -$3.11 million (-154.13%) on September 30, 2024.
- Over the past year, SONN quarterly working capital has dropped by -$3.11 million (-154.13%).
- SONN quarterly working capital is now -104.94% below its all-time high of $22.11 million, reached on September 30, 2021.
Performance
SONN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
SONN Working Capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -38.9% | -154.1% |
3 y3 years | -104.9% | -154.1% |
5 y5 years | +61.6% | -154.1% |
SONN Working Capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -104.9% | +60.3% | -106.7% | +70.4% |
5 y | 5-year | -104.9% | +61.6% | -104.9% | +93.3% |
alltime | all time | -104.9% | +61.6% | -104.9% | +93.3% |
Sonnet BioTherapeutics Holdings Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | -$1.09 M(+38.9%) | -$1.09 M(-154.1%) |
Jun 2024 | - | $2.02 M(-17.9%) |
Mar 2024 | - | $2.46 M(+24.8%) |
Dec 2023 | - | $1.97 M(-350.4%) |
Sep 2023 | -$786.40 K(-71.4%) | -$786.40 K(-124.8%) |
Jun 2023 | - | $3.17 M(-39.9%) |
Mar 2023 | - | $5.27 M(-242.7%) |
Dec 2022 | - | -$3.70 M(+34.3%) |
Sep 2022 | -$2.75 M | -$2.75 M(-514.2%) |
Jun 2022 | - | $664.10 K(-92.1%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $8.40 M(-48.3%) |
Dec 2021 | - | $16.24 M(-26.5%) |
Sep 2021 | $22.11 M(+658.9%) | $22.11 M(+1711.1%) |
Jun 2021 | - | $1.22 M(-39.0%) |
Mar 2021 | - | $2.00 M(-177.1%) |
Dec 2020 | - | -$2.59 M(-189.0%) |
Sep 2020 | $2.91 M(-202.4%) | $2.91 M(+971.4%) |
Jun 2020 | - | $271.90 K(-101.7%) |
Mar 2020 | - | -$16.39 M |
Sep 2019 | -$2.85 M | - |
FAQ
- What is Sonnet BioTherapeutics Holdings annual working capital?
- What is the all time high annual working capital for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings annual working capital year-on-year change?
- What is Sonnet BioTherapeutics Holdings quarterly working capital?
- What is the all time high quarterly working capital for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings quarterly working capital year-on-year change?
What is Sonnet BioTherapeutics Holdings annual working capital?
The current annual working capital of SONN is -$1.09 M
What is the all time high annual working capital for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high annual working capital is $22.11 M
What is Sonnet BioTherapeutics Holdings annual working capital year-on-year change?
Over the past year, SONN annual working capital has changed by -$305.90 K (-38.90%)
What is Sonnet BioTherapeutics Holdings quarterly working capital?
The current quarterly working capital of SONN is -$1.09 M
What is the all time high quarterly working capital for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high quarterly working capital is $22.11 M
What is Sonnet BioTherapeutics Holdings quarterly working capital year-on-year change?
Over the past year, SONN quarterly working capital has changed by -$3.11 M (-154.13%)